Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.409EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.83EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.310EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.362.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.162EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Y.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.86EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.154EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.4.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.41EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.137EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.446EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.76 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.398EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.163EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.3 (Theta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.38.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAVEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.77EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BY.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.123 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.71EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.12.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DN.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.51EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XREWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.350.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.254EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.39.1.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.418EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.9.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.122EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAJEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.431EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.168EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.6 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AZ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.97EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used